|
Originally published In Press as doi:10.1074/jbc.M003575200 on July 5, 2000
J. Biol. Chem., Vol. 275, Issue 40, 31297-31304, October 6, 2000
Purification, Characterization, and cDNA Cloning of a Novel
Acidic Endoglycoceramidase from the Jellyfish, Cyanea
nozakii*
Yasuhiro
Horibata,
Nozomu
Okino,
Sachiyo
Ichinose ,
Akira
Omori , and
Makoto
Ito§
From the Department of Bioscience and Biotechnology, Graduate
School of Bioresource and Bioenvironmental Sciences, Kyushu University,
6-10-1, Hakozaki, Higashi-ku, Fukuoka 812-8581 Japan and the
Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida 194-8511, Tokyo, Japan
Received for publication, April 27, 2000, and in revised form, June 27, 2000
 |
ABSTRACT |
Endoglycoceramidase (EC 3.2.1.123) is an enzyme
capable of cleaving the glycosidic linkage between oligosaccharides and ceramides in various glycosphingolipids. We report here the
purification, characterization, and cDNA cloning of a novel
endoglycoceramidase from the jellyfish, Cyanea nozakii. The
purified enzyme showed a single protein band estimated to be 51 kDa on
SDS-polyacrylamide gel electrophoresis. The enzyme showed a pH optimum
of 3.0 and was activated by Triton X-100 and Lubrol PX but not by
sodium taurodeoxycholate. This enzyme preferentially hydrolyzed
gangliosides, especially GT1b and GQ1b, whereas neutral
glycosphingolipids were somewhat resistant to hydrolysis by the enzyme.
A full-length cDNA encoding the enzyme was cloned by 5'- and
3'-rapid amplification of cDNA ends using a partial amino acid
sequence of the purified enzyme. The open reading frame of 1509 nucleotides encoded a polypeptide of 503 amino acids including a signal
sequence of 25 residues and six potential
N-glycosylation sites. Interestingly, the Asn-Glu-Pro sequence, which is the putative active site of Rhodococcus
endoglycoceramidase, was conserved in the deduced amino acid sequences.
This is the first report of the cloning of an endoglycoceramidase from
a eukaryote.
 |
INTRODUCTION |
Glycosphingolipids
(GSLs),1 amphipathic
compounds consisting of oligosaccharides and ceramides, are
characteristic components of plasma membrane. They are considered to be
receptors for microorganisms and their toxins, as well as modulators of
cell growth and differentiation (1). Recently, GSLs were found to be
enriched with other sphingolipids and cholesterol to form microdomains
on the ectoplasmic membrane (2). These lipid domains assemble receptors
and signaling molecules coupled to Src family kinases and G-proteins on
their inner surface and mediate membrane trafficking and signaling
activities (3).
Endoglycoceramidase (EGCase) is a GSL-specific enzyme that catalyzes
the hydrolysis of the glycosidic linkage between oligosaccharides and
ceramides of various GSLs (4). This enzyme was first discovered in a
culture supernatant of the actinomycete, Rhodococcus sp. strain G-74-2 (5), and later found in bacteria (6). A similar enzyme,
called ceramide glycanase (CGase), has been found in leeches (7),
earthworms (8), and clams (9). Three isoforms of EGCase (EGCase I, II,
and III), each differing in molecular weight, pI, and substrate
specificity, were isolated from the culture supernatant of
Rhodococcus sp. M-750, a mutant of the wild strain G-74-2
(4).
Recently, we cloned and sequenced the gene encoding EGCase II of
Rhodococcus sp. M-777 and showed that the deduced amino acid sequence contained the Asn-Glu-Pro (NEP) sequence, which is commonly conserved as part of the active site region of family A cellulases (endo-1,4- -glucanase) (10). The NEP sequence was also found in the
deduced amino acid sequence of the newly cloned EGCase gene of
Rhodococcus sp. C9 (11). Replacement of the Glu residue in
the NEP sequence with Gln or Asp by site-directed mutagenesis caused
drastic loss of enzymatic activity in both M-777 and C9 EGCases,
indicating that the Glu residue in the NEP sequence of EGCase plays an
important role in its enzymatic activity (11). Molecular cloning of
EGCase/CGase from eukaryotes has not yet been conducted.
In this paper, we report a novel EGCase from the jellyfish,
Cyanea nozakii, which is a glycoprotein with
N-glycans and acts on GSLs most efficiently at pH 3.0. The
substrate specificity of jellyfish EGCase is completely different from
those of other EGCases and CGases reported so far; i.e. the
jellyfish enzyme hydrolyzed gangliosides, especially b-series
polysialogangliosides, much faster than neutral GSLs. This paper also
reports the first molecular cloning of a eukaryotic EGCase and reveals
that the NEP sequence is commonly conserved in the sequences of EGCases of not only prokaryotes but also eukaryotes.
 |
EXPERIMENTAL PROCEDURES |
Materials
Jellyfish (C. nozakii) were collected at Nishinoura
in Wakayama, Japan, and stored at 80 °C until use. GM1 was
prepared from crude bovine brain ganglioside using sialidase-producing
bacteria, Psedomonas sp. YF-2, by the method described in
Ref. 12. GQ1b, GT1b, and globoside were obtained from Iatron
Laboratories Inc. (Tokyo, Japan). GD1a, GD1b, GD3, GM3,
asialo-GM1, lactosylceramide (LacCer), galactosylceramide, and
glucosylceramide were from Wako Pure Chemical Industries (Osaka,
Japan). Synthetic lactoside, 2-N-dodecanoylamino-4-nitrophenyl-O- -lactoside,
was kindly donated from Dr. T. Yamagata (Japan Institute of Leather
Research). Lyso-GM1 was prepared by digestion of GM1 with sphingolipid
ceramide N-deacylase (13) by the method described in Ref.
14. Triton X-100 and Lubrol PX were obtained from Sigma and Nacalai
Tesque Inc. (Kyoto, Japan), respectively. A precoated Silica Gel 60 TLC
plate was obtained from Merck. All other reagents were of the highest
purity available.
EGCase Assay
The reaction mixture contained 10 nmol of GM1 and an appropriate
amount of the enzyme in 20 µl of 25 mM sodium acetate
buffer, pH 3.0, containing 0.2% (w/v) Triton X-100. Following
incubation at 37 °C for the times indicated, the reaction was
stopped by heating in a boiling water bath for 5 min. The reaction
mixture was evaporated to dryness, redissolved in 10 µl of 50%
methanol, and applied to TLC plates, which were then developed with
chloroform, methanol, 0.2% CaCl2 (4/4/1, v/v/v).
For determination of hydrolysis of polysialogangliosides, the TLC
plates were developed with chloroform, methanol, 0.2%
CaCl2 (2/3/1, v/v/v). GSLs and oligosaccharides were
visualized by spraying the TLC plates with
orcinol-H2SO4 reagent and scanning them with a
Shimadzu CS-9300 chromatoscanner with the reflectance mode set at 540 nm. The extent of hydrolysis was calculated as follows: hydrolysis
(%) = (peak area for oligosaccharide released) × 100/(peak
area for remaining substrate + peak area for oligosaccharide released).
One unit of the EGCase was defined as the amount of enzyme that
catalyzed the release of 1 µmol of GM1/min under the conditions
described above. The hydrolysis of 2-N-dodecanoylamino-4-nitrophenyl-O- -lactoside
was examined according to the method described by Miura et
al. (15).
Purification of EGCase from the Jellyfish, C. nozakii
Step 1: 80% Ammonium Sulfate Precipitation--
Jellyfishes
(2.5 kg) were homogenized in a Waring blender and centrifuged at 8,000 rpm for 30 min. The supernatant was 80% saturated with ammonium
sulfate. After standing overnight, the precipitate was dissolved in 500 ml of 20 mM sodium acetate buffer, pH 5.0, containing 2 M NaCl and 0.2% Lubrol PX. After gentle stirring overnight, the supernatant solution (500 ml) was subjected to further
purification procedures.
Step 2: Phenyl-Sepharose Fast Flow Chromatography--
The
enzyme solution obtained above was applied to a phenyl-Sepharose 6 Fast
Flow column (75 ml; Amersham Pharmacia Biotech) equilibrated with 20 mM sodium acetate buffer, pH 5.0, containing 2 M NaCl at a flow rate of 5 ml/min, using a BPLC-600FC HPLC
system (Yamazen Co., Osaka, Japan), and the effluent was fractionated into each 10-ml portion. After the column was washed with 20 mM sodium acetate buffer, pH 5.0, the enzyme was eluted
from the column with 20 mM sodium acetate buffer, pH 5.0, containing 1% Lubrol PX.
Step 3: SP-Sepharose Fast Flow Chromatography--
The active
fractions from the phenyl-Sepharose chromatography (300 ml) were
subjected to chromatography using a SP-Sepharose Fast Flow column (55 ml; Amersham Pharmacia Biotech) previously equilibrated with 20 mM sodium acetate buffer, pH 5.0, containing 0.1% Lubrol
PX, using BPLC-600FC HPLC system. After washing the column with the
same buffer, the enzyme was eluted from the column with a linear
gradient of 0-0.4 M NaCl in the same buffer at a flow rate
of 5 ml/min. Fractions each of 10 ml were collected, and those
containing enzyme activity were pooled and dialyzed against 20 mM sodium acetate buffer, pH 6.0.
Step 4: Chelating Sepharose Chromatography--
The
dialyzed enzyme solution (250 ml) was applied to a HiTrap Chelating
column (chelated with Cu2+, 5 ml, Amersham Pharmacia
Biotech), equilibrated with 20 mM sodium acetate buffer, pH
6.0, containing 0.1% Lubrol PX at a flow rate of 5 ml/min using a
P.S.L.C. system (Amersham Pharmacia Biotech), and 10-ml
fractions were collected. After washing the column with the same buffer
and subsequently with 0.5 M NaCl, the enzyme was eluted
from the column with 1 M NH4Cl. The active
fractions were pooled and dialyzed against 20 mM sodium
acetate buffer, pH 5.0.
Step 5: CM-5PW Chromatography--
The dialyzed enzyme solution
(195 ml) was applied to a TSKgel CM-5PW column (5 × 50 mm; TOSOH
Co., Tokyo, Japan) that had been equilibrated with 20 mM
sodium acetate buffer, pH 5.0, containing 0.1% Lubrol PX, at a flow
rate of 1 ml/min using the BioCAD SPRINT system (PerSeptive Biosystems,
Inc.). The column was washed with the same buffer and developed with a
linear NaCl gradient from 0 to 0.1 M in the same buffer.
The fractions containing the enzyme were concentrated, and the buffer
was replaced with 20 mM sodium acetate buffer, pH 6.0, using a centrifugal concentrator (Centriprep-10, Amicon,
Inc.).
Step 6: Heparin-Sepharose Chromatography--
The concentrated
enzyme (21 ml) was applied to a HiTrap Heparin column (1 ml; Amersham
Pharmacia Biotech) previously equilibrated with 20 mM
sodium acetate buffer, pH 6.0, containing 0.1% Lubrol PX at a flow
rate of 1 ml/min. The enzyme was passed through the column, while
contaminating proteins were adsorbed and eluted with 1 M
NaCl in the same buffer.
Superdex 200HR Gel Filtration of the Purified EGCase
100 µl of the purified enzyme was applied to a Superdex 200HR
column (10 × 300 mm; Amersham Pharmacia Biotech), which had been
equilibrated with 20 mM sodium acetate buffer, pH 6.0, containing 0.3% Lubrol PX and 0.1 M NaCl at a flow rate of
0.5 ml/min using the BioCAD system, and fractions of 1.0 ml each were
collected and subjected to the assay of EGCase.
Protein Assay and SDS-PAGE
Measurement of protein was determined by the bicinchoninic acid
protein assay (Pierce) with bovine serum albumin as the standard. SDS-PAGE was carried out according to the method of Laemmli (16). The
proteins on SDS-PAGE were visualized by a silver-staining solution (17)
and determined with a Shimadzu CS-9300 chromatoscanner with the
reflection mode set at 540 nm.
Native PAGE
The purified EGCase was applied onto 4-20% Tris-glycine gel
(NOVEX). A duplicate gel was cut into 3-mm slices. Each slice was
crushed in 150 µl of 20 mM sodium acetate buffer, pH 5.0, containing 0.1% Triton X-100. After centrifugation at 15,000 rpm for 5 min, an aliquot (10 µl) of the supernatant of the extract was assayed
for enzyme activity using GM1 as the substrate. The reaction mixture
was incubated at 37 °C for 18 h. The extent of hydrolysis was
determined as described above.
Lectin Blotting
The purified enzyme was subjected to SDS-PAGE under reducing
conditions and then transferred onto polyvinylidene difluoride membranes (Hybond-P; Amersham Pharmacia Biotech). The membranes were
blocked with 1% bovine serum albumin in TBS (20 mM
Tris-HCl buffer, pH 7.5, containing 100 mM NaCl) for 1 h with gentle shaking. For specific detection of glycan moieties, the
membranes were treated with 1 µg/ml of horseradish peroxidase-labeled
lectins (Seikagaku Co., Tokyo, Japan) in the same buffer for 1 h
at room temperature. After washing three times with TBS containing
0.1% Tween 20 for 10 min, the membranes were incubated in ECL Plus solution (Amersham Pharmacia Biotech) and determined with a STORM (Molecular Dynamics, Inc., Sunnyvale, CA).
Glycopeptidase F Treatment
The purified enzyme was denatured in boiling water bath for 3 min in 5 µl of 50 mM Tris-HCl buffer, pH 8.6, containing
0.5% SDS and 0.75% -mercaptoethanol. The denatured enzyme was then incubated at 37 °C for 18 h with 0.5 milliunits of
glycopeptidase F (Takara Shuzo Co., Shiga, Japan) in 20 µl of the
same buffer containing 1% Nonidet P-40.
Measurement of Other Enzymes
Exoglycosidases and proteases were assayed using
p-nitrophenyl glycoside (18) and Azocoll (19), respectively,
as the substrates. Neuraminidase was assayed using
4-methylumbelliferyl-N-acethylneuraminic acid as
substrate. The activities of sphingomyelinase and ceramidase were
measured using C12-4-nitrobenzo-2-oxa-1,3-diazole-sphingomyelin and C12-4-nitrobenzo-2-oxa-1,3-diazole-ceramide, respectively, by the
method described in Refs. 14 and 20.
Amino Acid Microsequencing
The purified enzyme was treated with glycopeptidase F and then
concentrated using a Y-shaped gel (160 × 160 × 2 mm)
modified form of a funnel-shaped one (21). Two protein bands (45 and 46 kDa) were visualized by staining with Coomassie Brilliant Blue, and
thus each band was cut out separately, reduced with dithiothreitol, and
loaded again on a well of a normal SDS-PAGE. After
electrophoresis, the gel was blotted on a polyvinylidene difluoride
membrane (ProBlott, PE-Biosystems) and stained with Coomassie Brilliant
Blue. The 45- and 46-kDa protein bands were cut out and treated
in situ with lysylendopeptidase AP-1 (Wako Pure Chemical
Industries). Peptides released from the membrane were fractionated with
a reversed-phase HPLC column of C8 (RP-300, 1.0 × 100 mm;
PE-Biosystems) and sequenced with a pulse-liquid phase protein
sequencer (Procise 492 cLc, PE-Biosystems).
First Strand cDNA Synthesis
To obtain the partial cDNA sequence encoded the EGCase, we
synthesized the first strand cDNA from the jellyfish. Total RNA and
mRNA were obtained from 4 g of the tentacle portion of the jellyfish using Sepasol-RNA I (Nacalai Tesque, Japan) and FastTrack 2.0 kit (Invitrogen), respectively. First strand cDNA was synthesized from 2 µg of mRNA using an AMV Reverse Transcriptase
First-strand cDNA Synthesis kit (Life Sciences, Inc.).
Isolation of a Partial cDNA Encoding the EGCase
Based on the amino acid sequences of peptides derived from the
purified EGCase, degenerate primers of both sense and antisense strands
were designed. Sense oligonucleotide primer, NSout
(5'-GTNAAYCCNGARACNCA-3'), was synthesized from the N-terminal peptide
sequences, and for the second round nested PCR, NSin
(5'-CCNGARACNCARCARYT-3') was designed. Antisense primers, 559Aout
(5'-ATHTAYAGNGGNCGYTT-3') and 547Aout (5'-CCRAGYATYATYACYAT-3'),
were synthesized based on the internal amino acid sequences of C-559
and C-547/562, respectively. For the second round nested PCR, 559Ain
(5'-CGYTTNCCRAGYAAHTA-3') and 547Ain (5'-ATNCGYAGNGGNGGNCC-3')
were used. The first round PCR was performed using two sets of
the primers (NSout and 559Aout, NSout and 547Aout) with first strand
cDNA as a template in a GeneAmp PCR System 9700 (PE-Biosystems)
using AmpliTaq Gold (PE-Biosystems). The second round nested PCR was
primed with each first round PCR product as a template using nested
primers (NSin and 559Ain, NSin and 547Ain). The PCR products were
cloned into pGEM T-easy vector (Promega), and their DNA sequences were determined.
5'- and 3'-RACE
To obtain the 5'- and 3'-end, the SMART RACE cDNA
Amplification kit (CLONTECH) was used. 5'-RACE
first strand cDNA was primed from 0.75 µg of mRNA with
Superscript II reverse transcriptase (Life Technologies, Inc.) using a
SMART II oligonucleotide and a 5'-RACE cDNA synthesis primer. The
5'-end of the cDNA was amplified by PCR using gene-specific primer
1 (5'-CTGCGGATTCAGGGGGTATTTGTCTTCA-3') and a universal primer
mix and 5'-RACE first strand cDNA as a template, using the
Advantage 2 PCR kit (CLONTECH). The 3'-RACE first
strand cDNA was primed using 3'-RACE cDNA synthesis primer. The
3'-end of the cDNA was obtained by PCR using a universal primer mix
and gene-specific primer 2 (5'-CTTGGTATGATGCTGCCAGGCTATGTGC-3') and
3'-RACE first strand cDNA as a template. The 5'- and 3'-RACE PCR
products were cloned into the pGEM T-easy vector, and their DNA
sequences were determined.
Construction of a Full-length cDNA
An upstream (EGC-N) and a downstream primer (EGC-C), each
containing an EcoRI site, were designed from the N and C
terminus of the open reading frame, respectively. A full-length
cDNA was prepared by PCR using these primers and 5'- RACE first
strand cDNA as a template with Pyrobest DNA polymerase (Takara
Shuzo Co., Japan). After digestion with EcoRI, a PCR product
was cloned into a pBluescript II SK+ (STRATAGENE). 14 clones obtained
were sequenced. The full-length PCR product was also directly sequenced to minimize potential PCR artifacts.
Other Methods
Nucleotide sequences were determined on both strands by the
dideoxynucleotide chain termination method with a Bigdye Terminator Cycle Sequencing Ready Reaction Kit (PE-Biosystems) and a DNA Sequencer
(model 377A, PE-Biosystems). The nucleotide and amino acid sequences
were evaluated using the DNASIS computer program developed by Hitachi
Software Engineering.
 |
RESULTS |
Purification of EGCase from the Jellyfish, C. nozakii--
EGCase
was purified from extracts of the jellyfish by ammonium sulfate
precipitation, followed by sequential chromatography with
phenyl-Sepharose 6 FF, SP-Sepharose FF, HiTrap Chelating, TSKgel
CM-5PW, and HiTrap Heparin. As shown in Table
I, the enzyme was purified 1,260-fold
with 20.5% recovery. The final preparation showed a single, but broad,
protein band after staining with silver solution under both reducing
(Fig. 1A) and nonreducing
conditions (data not shown). The apparent molecular mass of the EGCase
was estimated to be 51 kDa on SDS-PAGE (Fig. 1B). The
elution profile of EGCase activity on chromatography with a Superdex
200HR coincided exactly with that of the 51-kDa band on SDS-PAGE, and
no other co-eluted bands were observed (Fig.
2A). The purified enzyme also showed a single protein band on the native PAGE that corresponded to
the active fractions (Fig. 2B). These results indicated that the 51-kDa protein identified on SDS-PAGE was definitely the EGCase. The protein was stained with horseradish peroxidase-labeled
concanavalin A, but hardly with Ricinus communis agglutinin
I (RCA I) and wheat germ agglutinin (WGA) (Fig.
3A), and converted to 45- and
46-kDa bands on SDS-PAGE after exhaustive digestion with glycopeptidase F (Fig. 3B). These results showed that the jellyfish EGCase
was glycosylated with N-glycans, possibly possessing
mannosyl or glucosyl residues.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1.
SDS-PAGE of purified EGCase of the jellyfish
(A) and determination of molecular weight
(B). A, the final preparation of
EGCase was analyzed by SDS-PAGE in the presence of -mercaptoethanol.
Proteins were stained with a silver-staining solution. B,
standard proteins (molecular mass in parentheses) were
phosphorylase b (94 kDa), bovine serum albumin (67 kDa),
ovalbumin (43 kDa), carbonic anhydrase (30 kDa), and trypsin inhibitor
(20.1 kDa).
|
|

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Gel filtration chromatography
(A) and native PAGE (B) of the
purified EGCase of the jellyfish. A, gel filtration
chromatography on HPLC using a Superdex 200 HR column and SDS-PAGE of
each fraction. HPLC was performed as described under "Experimental
Procedures." Proteins were stained with silver-staining solution, and
content of the 51-kDa protein was determined using a Shimadzu CS-9300
chromatoscanner. Standard proteins (molecular mass in parentheses) were
blue dextran (2,000 kDa), -amylase (200 kDa), apotransferrin (81 kDa), ovalbumin (43 kDa), and cytochrome c (12.4 kDa).
B, purified enzyme was analyzed by native PAGE using a
4-20% gradient acrylamide gel (NOVEX) as described under
"Experimental Procedures." Proteins were stained with silver
solution. Unstained gels were cut into 3-mm slices, and each fraction
was assayed using GM1 as the substrate. Standard proteins (molecular
mass in parentheses) were thyroglobulin (669 kDa), ferritin (443 kDa),
lactate dehydrogenase (139.9 kDa), bovine serum albumin (67 kDa), and
trypsin inhibitor (20.1 kDa).
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 3.
Lectin blotting of the EGCase
(A) and SDS-PAGE of the
de-N-glycosylated protein (B).
A, lectin blotting was conducted with horseradish
peroxidase-labeled concanavalin A (ConA), R. communis agglutinin I (RCA I), and wheat germ
agglutinin (WGA), respectively, as described under
"Experimental Procedures." B, purified EGCase was
treated with glycopeptidase F as described under "Experimental
Procedures." After digestion, the samples were subjected to 10%
SDS-PAGE under reducing conditions. Protein bands were stained with
silver-staining solution. Lane 1, purified
EGCase; lane 2, after glycopeptidase F
treatment.
|
|
Properties of the Jellyfish EGCase--
Jellyfish EGCase exhibited
maximal activity around pH 3.0 with GM1 (Fig.
4A) and asialo GM1 (Fig.
4B) as the substrates. The EGCase required detergents for
hydrolysis of GSLs. The optimal concentrations of Triton X-100 and
Lubrol PX were 0.2 and 0.4%, respectively. Taurodeoxycholate strongly
inhibited the enzyme activity (Fig. 4C), and SDS completely
inhibited the EGCase activity at a concentration of 0.1% (data not
shown). Among the metal ions examined, Hg2+ completely
inhibited the enzyme activity at 2 mM, whereas
Cu2+ and Zn2+, which are potent inhibitors of
microbial EGCases, had no effects on enzyme activity at the final
concentration of 5 mM. Li+, K+,
Mn2+, Ni2+, Ca2+, Mg2+,
and EDTA had no significant effects on the activity at 5 mM. Fig. 4D shows the Lineweaver-Burk plot and
substrate saturation curve (inset). Apparent
Km and Vmax values of this
enzyme for GM1 were estimated to be 0.35 mM and 4.4 units/mg, respectively.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 4.
General properties of the jellyfish
EGCase. The pH dependence of EGCase activity was assayed using GM1
(A) and asialo-GM1 (B) as the substrates as
described under "Experimental Procedures." , KCl-HCl buffer, pH
1.5-2.0; , glycine-HCl buffer, pH 2.0-3.0; , sodium acetate
buffer, pH 3.0-6.0; , sodium phosphate buffer, pH 6.0-8.0.
C, effects of detergents on EGCase. The activity was
determined using GM1 as the substrate as described under
"Experimental Procedures." , Triton X-100; , Lubrol PX; ,
taurodeoxycholate. D, Lineweaver-Burk plots for the action
of the jellyfish EGCase on GM1. GM1 at the indicated concentrations was
incubated with 20 microunits of the enzyme at 37 °C for 60 min in 20 µl of 25 mM sodium acetate buffer, pH 3.0, containing
0.4% Triton X-100. The inset shows the substrate saturation
curve.
|
|
Substrate Specificity--
Table II
summarizes the extent of the hydrolysis of various GSLs by the
jellyfish EGCase under conditions that may reflect the relative initial
reaction velocity (condition I) and for determining the degree of
hydrolysis after exhaustive digestion (condition II). Of all GSLs
tested, gangliosides appeared to be good substrates under both
conditions, GT1b being most favored by the enzyme, followed by GQ1b and
GM1. Neutral GSLs, such as asialo-GM1 and LacCer, were hydrolyzed
considerably more slowly than gangliosides. Gb4Cer was only slightly
hydrolyzed. No hydrolysis was observed for cerebrosides, lyso-GM1,
2-N-dodecanoylamino-4-nitrophenyl-O- -lactoside, sphingomyelin, and ceramide even under condition II. Fig.
5 shows the time course for hydrolysis of
GM1, GT1b, and LacCer by the jellyfish enzyme and
Rhodococcus EGCase II. It was found that the jellyfish
enzyme hydrolyzed GT1b much more rapidly than did EGCase II (Fig.
5B), although the reaction velocity for GM1 by both enzymes
was almost the same (Fig. 5A). LacCer, by contrast, was
hydrolyzed by the jellyfish enzyme considerably more slowly compared
with the microbial enzyme (Fig. 5C).
View this table:
[in this window]
[in a new window]
|
Table II
Specificity of EGCase from the jellyfish, C. nozakii
Various GSLs were incubated at 37 °C for 30 min (condition I) or
16 h (condition II) with 0.1 milliunits of the enzyme in 20 µl
of 25 mM sodium acetate buffer, pH 3.0, containing 0.2%
Triton X-100. GSLs and oligosaccharides were separated by TLC and
visualized by spraying with orcinol-H2SO4 reagent and
determined as described under "Experimental
Procedures."
|
|

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 5.
Time course for the hydrolysis of GSLs by
jellyfish and Rhodococcus EGCases. 10 nmol of GM1
(A), GT1b (B), and LacCer (C) was
incubated with 0.1 milliunit of each EGCase at 37 °C for the times
indicated as described under "Experimental Procedures." For
jellyfish and Rhodococcus EGCases, 25 mM sodium
acetate buffer, pH 3.0, containing 0.2% Triton X-100 and 25 mM sodium acetate buffer, pH 5.5, containing 0.4% Triton
X-100 were used, respectively. , jellyfish EGCase; ,
Rhodococcus EGCase II.
|
|
Amino Acid Sequence of the Purified EGCase--
The 45- and 46-kDa
polypeptides generated after glycopeptidase F treatment were separately
digested with lysylendopeptidase and subjected to amino acid
microsequencing. The N-terminal amino acid sequences of both native polypeptides were also determined. Table III shows the partial amino acid sequences of the EGCase, in which C-549, C-547, and C-558 were obtained from the 45-kDa polypeptide, and C-552, C-562, and C-559 were obtained from the 46-kDa
polypeptide. The N terminus as well as one of the internal amino
acid sequences of both polypeptides were completely identical (Table
III). Furthermore, the peptide map of the 45-kDa polypeptide after
digestion with lysylendopeptidase was almost identical to that of the
46-kDa one (data not shown). These results indicated that both
polypeptides were derived from the same 51-kDa protein.
View this table:
[in this window]
[in a new window]
|
Table III
Peptide sequences of EGCase from the jellyfish, C. nozakii
Peptide sequences were determined by Edman sequencing.
|
|
Cloning of the EGCase cDNA--
PCR was performed using two
sets of primers (NSout and 559Aout, NSout and 547Aout) and the first
strand cDNA as the template. The first round PCR product was then
used as a template for nested PCR amplification using nested primers
(NSin and 559Ain, NSin and 547Ain). As a result, the 620- and 820-bp
PCR products were specifically amplified. The former contained
C-549/552, C-558, C-559, and the later contained C-549/552,
C-558, C-559, and C-547/562 (Table III). To obtain the 5'- and
3'-terminal segments of the cDNA, 5'- and 3'-RACE were performed.
The 650-bp PCR product was amplified from the 5'-RACE, and the 1,490-bp
product was from the 3'-RACE. The sequences of the overlapping cDNA
fragments contained an initiation codon in agreement with the Kozak
rule (22) and a termination codon. The full-length cDNA amplified
by PCR was cloned into pBluescript II SK+ vector, and 14 independent
clones were sequenced. As a result, the open reading frame of eight
clones showed the identical nucleotide sequences as shown in Fig.
6A (J-EGCase; AB047321).
However, other six clones showed minor variation, in which T at
position 164, C at 311, T at 526, and C at 794 were replaced with C, T,
C, and T, respectively, with the result that Leu172 could
be replaced with Pro (J-EGCase P; AB047322). This variation was also
confirmed by direct cycle sequencing of the full-length PCR product,
suggesting that two variants of EGCase gene are present in the
jellyfish.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 6.
Nucleotide and deduced amino acid sequences
(A) and hydropathy plot (B) of the
jellyfish EGCase. A, the deduced amino acid sequence is
shown in one-letter amino acid code below the nucleotide
sequence. Amino acid residues are numbered beginning with
the first methionine, and the translation termination codon is denoted
by an asterisk. The signal sequence is in boldface
type. Amino acids determined by peptide sequencing are
underlined. Potential N-linked glycosylation
sites are boxed, and the putative active site (NEP sequence)
is double-boxed. The double underline in the
3'-untranslated region indicates the polyadenylation site.
B, the deduced amino acid sequence of the EGCase was
analyzed by the method of Kyte and Doolittle for hydropathy plotting
(23). Amino acid residues are numbered beginning with the
first methionine.
|
|
DNA and Deduced Amino Acid Sequence of the EGCase--
Fig.
6A shows the nucleotide and the deduced amino acid sequences
of the jellyfish EGCase. The 1,509-bp open reading frame encodes 503 amino acid residues containing six potential N-glycosylation sites. A polyadenylation site was found in the 3'-untranslated region,
indicating that the EGCase is not derived from symbiotical bacteria or
actinomycetes. From the deduced amino acid sequence, the molecular mass
and pI of the EGCase were calculated to be 54,641 and 5.61, respectively. The deduced amino acid sequence contained all the
sequences obtained from the purified enzyme after digestion with
N-glycanase (Fig. 6A), except for
Asn72 and Asn307, which were determined as Asp
from the peptide sequence (Table III), indicating that
N-glycans were precisely coupled to these Asn residues. A
hydrophobic motif composed of 25 amino acid residues, a putative signal
sequence, was found just before the N terminus of the enzyme. The
presence of the hydrophobic motif near the N terminus was also clearly
indicated by hydrophobicity plot analysis (Fig. 6B). The
open reading frame showed 21.9% identity to that of
Rhodococcus EGCase II at the amino acid levels (Fig.
7). Interestingly, the NEP sequence,
which is part of the active site of Rhodococcus EGCase II,
was completely conserved in the deduced amino acid sequence of the
jellyfish enzyme (Fig. 7). We detected EGCase activity in the cell
lysate of CHOP cells when the cells were transfected with a plasmid
containing the cDNA encoding the jellyfish EGCase, while no EGCase
activity was found in untransfected CHOP cells or mock transfectants
(data not shown).

View larger version (57K):
[in this window]
[in a new window]
|
Fig. 7.
Alignment of jellyfish and
Rhodococcus EGCases. Jellyfish EGCase and
Rhodococcus EGCase II were aligned using the CLUSTAL
algorithm (24). Identical amino acids are indicated by an
asterisk, and chemically similar amino acids are indicated
by dots. Gaps inserted into the sequences are indicated by
dashed lines. The NEP sequence is
boxed.
|
|
 |
DISCUSSION |
Purified EGCase from the jellyfish, C. nozakii, showed
several unique characteristics compared with other EGCases and CGases reported so far. Lectin blotting using concanavalin A as well as
glycopeptidase F treatment of the purified jellyfish EGCase showed that
the enzyme was glycosylated with N-glycans. The deduced amino acid sequence of the jellyfish EGCase indicated six potential N-glycosylation sites. By contrast, there have been no
reports of the presence of glycans in other EGCases/CGases (4, 6-9). Second, the jellyfish EGCase shows a pH optimum at 3.0, while those of
actinomycetes, leeches, earthworms, and clams have been reported to
range from 4.0 to 5.5, indicating that the jellyfish enzyme is the most
acidic EGCase (4, 6-9). This result suggests that the jellyfish enzyme
could be located in lysosomes. Third, the activity of the jellyfish
enzyme was not affected by Zn2+ and Cu2+ at a
concentration of 5 mM, while other EGCases/CGases were
strongly inhibited by these metal ions (4, 6-9). Fourth, the
hydrolysis of GM1 by the jellyfish enzyme was enhanced by Triton X-100
but strongly inhibited by taurodeoxycholate. In contrast, the activity of the leech enzyme was inhibited by Triton X-100, whereas
taurodeoxycholate activated both the microbial and leech enzymes (4,
7). Finally, the jellyfish enzyme hydrolyzed gangliosides, especially
b-series polysialogangliosides, such as GT1b and GQ1b, much more
rapidly than neutral GSLs such as LacCer and asialo-GM1, while both the microbial and leech enzymes hydrolyzed neutral GSLs much more rapidly
than these polysialogangliosides (4, 7). Jellyfish EGCase did not
hydrolyze lyso-GM1 under the experimental conditions we employed. On
the other hand, the leech and Rhodococcus enzymes cleaved
sphingosine glycans (4, 7), including lyso-GM1, suggesting that the
whole ceramide structure is required for hydrolysis of substrates by
the jellyfish EGCase but not by other enzymes.
We previously reported that the NEP sequence, the active site of family
A cellulases, was also the putative active site of Rhodococcus EGCase II (10). The present study clearly shows that the NEP sequence was also completely conserved in the jellyfish EGCase. In addition, two regions at positions
Leu131-Val137 and
Tyr414-Gly420 of the deduced amino acid
sequence of the jellyfish enzyme were also highly conserved in
Rhodococcus EGCase, suggesting that these portions are also
important for the catalytic and/or substrate-binding functions of
EGCase.
It should be noted that EGCase activity was found in all species of
jellyfish tested (Spirocodon saltator, Aequorea
coerulescens, Aurelia aurita, Chrysaora
melanaster, Rhopilema esculenta, and C. nozakii). In addition, the enzyme activity was also detected in a
freshwater hydra, Hydra magnipapillata. Both jellyfish and hydra are members of the Cnidaria, a group of animals that arose very
early in metazoan evolution. Some jellyfish including C. nozakii eat small fish that are digested in the gastro-vascular cavity by digestive enzymes such as proteases, lipases, and chitinases. Then digested particles are incorporated by phagocytosis and further degraded in phagosomes/lysosomes (25). EGCase seems to be localized in
phagosomes/lysosomes, since the enzyme shows an extremely acidic pH
optimum (pH 3.0) and is glycosylated with N-glycans.
Furthermore, the putative lysosome-associated glycoprotein motif was
found in the sequence of the jellyfish EGCase
(Phe363-His387) (26). Invertebrates generally
do not express gangliosides, whereas polysialogangliosides are often
found in fish brains (27). Thus, the jellyfish EGCase could function to
catabolize the diet-derived glycosphingolipids, possibly in
phagosomes/lysosomes. Further study is necessary to confirm the precise
location of EGCase in the jellyfish and hydra.
This study is the first to isolate a full-length cDNA encoding a
eukaryotic EGCase, which shows an extremely acidic pH optimum. The
availability of the cDNA sequence of the EGCase should make it
possible to isolate new EGCases/CGases from other invertebrates, and
possibly vertebrates, and should help to define the physiological roles
of EGCases/CGases in eukaryotes. The jellyfish EGCase efficiently hydrolyzed polysialogangliosides, which were somewhat resistant to
hydrolysis by the EGCases and CGases reported previously, and will thus
facilitate further research into polysialogangliosides.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Tatsuya Yamagata for
the gift of
2-N-dodecanoylamino-4-nitrophenyl-O- -lactoside
and for encouragement. We also thank Dr. Takashi Nakamura of Kyushu
University for encouragement throughout the course of this study.
 |
FOOTNOTES |
*
This work was supported in part by Grant-in Aid for
Scientific Research (B) 09460051 from the Ministry of Education,
Science and Culture of Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AB047321 (J-EGCase) and AB047322 (J-EGCase P).
§
To whom all correspondence should be addressed: Dept. of
Bioscience and Biotechnology, Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan. Tel.: 81-92-642-2900; Fax: 81-92-642-2907; E-mail: makotoi@agr.kyushu-u.ac.jp.
Published, JBC Papers in Press, July 5, 2000, DOI 10.1074/jbc.M003575200
 |
ABBREVIATIONS |
The abbreviations used are:
GSL, glycosphingolipid;
CGase, ceramide glycanase;
EGCase, endoglycoceramidase;
PAGE, polyacrylamide gel electrophoresis;
PCR, polymerase chain reaction;
RACE, rapid amplification of cDNA ends;
HPLC, high pressure liquid chromatography;
bp, base pair. Abbreviations
and structures of GSLs are shown in Table II.
 |
REFERENCES |
| 1.
|
Hakomori, S.
(1981)
Annu. Rev. Biochem.
50,
733-764
|
| 2.
|
Simons, K.,
and Ikonen, E.
(1997)
Nature
387,
569-572
|
| 3.
|
Hakomori, S.,
Hanada, K.,
Iwabuchi, K.,
Yamamura, S.,
and Prinetti, A.
(1998)
Glycobiology
8,
xi-xviii
|
| 4.
|
Ito, M.,
and Yamagata, T.
(1989)
J. Biol. Chem.
264,
9510-9519
|
| 5.
|
Ito, M.,
and Yamagata, T.
(1986)
J. Biol. Chem.
261,
14278-14282
|
| 6.
|
Ashida, H.,
Yamamoto, K.,
Kumagai, H.,
and Tochikura, T.
(1992)
Eur. J. Biochem.
205,
729-735
|
| 7.
|
Zhou, B.,
Li, S.-C.,
Laine, R. A.,
Huang, R. T. C.,
and Li, Y.-T.
(1989)
J. Biol. Chem.
264,
12272-12277
|
| 8.
|
Li, Y.-T.,
Ishikawa, Y.,
and Li, S.-C.
(1987)
Biochem. Biophys. Res. Commun.
149,
167-172
|
| 9.
|
Basu, S. S.,
Dastgheib-Hosseini, S.,
Hoover, G.,
Li, Z.,
and Basu, S.
(1994)
Anal. Biochem.
222,
270-274
|
| 10.
|
Izu, H.,
Izumi, Y.,
Kurome, Y.,
Sano, M.,
Kondo, A.,
Kato, I.,
and Ito, M.
(1997)
J. Biol. Chem.
272,
19846-19850
|
| 11.
|
Sakaguchi, K.,
Okino, N.,
Izu, H.,
and Ito, M.
(1999)
Biochem. Biophys. Res. Commun.
260,
89-93
|
| 12.
|
Fukano, Y.,
and Ito, M.
(1997)
Appl. Environ. Microbiol.
63,
1861-1865
|
| 13.
|
Ito, M.,
Kurita, T.,
and Kita, K.
(1995)
J. Biol. Chem.
270,
24370-24374
|
| 14.
|
Nakagawa, T.,
Tani, M.,
Kita, K.,
and Ito, M.
(1999)
J. Biochem. (Tokyo)
126,
604-611
|
| 15.
|
Miura, Y.,
Arai, T.,
Ohtake, A.,
Ito, M.,
Yamamoto, K.,
and Yamagata, T.
(1999)
Glycobiology
9,
957-960
|
| 16.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 17.
|
Ohsawa, K.,
and Ebata, N.
(1983)
Anal. Biochem.
135,
409-415
|
| 18.
|
Li, Y.-T.,
and Li, S.-C.
(1972)
Methods Enzymol.
28,
702-713
|
| 19.
|
Moore, G. L.
(1969)
Anal. Biochem.
32,
122-127
|
| 20.
|
Tani, M.,
Kita, K.,
Komori, H.,
Nakagawa, T.,
and Ito, M.
(1998)
Anal. Biochem.
263,
183-188
|
| 21.
|
Dainese, H. P.,
Quadroni, M.,
Staudenmann, W.,
and James, P.
(1997)
Eur. J. Biochem.
264,
336-343
|
| 22.
|
Kozak, M.
(1986)
Cell
44,
283-292
|
| 23.
|
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132
|
| 24.
|
Thompson, J. D.,
Higgins, D. G.,
and Gibson, T. J.
(1994)
Nucleic Acid Res.
22,
4673-4680
|
| 25.
|
Paul, L. M.
(1981)
J. Cell Sci.
49,
311-339
|
| 26.
|
Fukuda, M.,
Viitala, J.,
Matteson, J.,
and Carlsson, S. R.
(1988)
J. Biol. Chem.
263,
18920-18928
|
| 27.
|
Ishizuka, I.,
and Wiegandt, H.
(1972)
Biochim. Biophys. Acta
260,
279-289
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Ishibashi, M. Kiyohara, N. Okino, and M. Ito
Synthesis of fluorescent glycosphingolipids and neoglycoconjugates which contain 6-gala oligosaccharides using the transglycosylation reaction of a novel endoglycoceramidase (EGALC)
J. Biochem.,
August 1, 2007;
142(2):
239 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. C. Caines, M. D. Vaughan, C. A. Tarling, S. M. Hancock, R. A. J. Warren, S. G. Withers, and N. C. J. Strynadka
Structural and Mechanistic Analyses of endo-Glycoceramidase II, a Membrane-associated Family 5 Glycosidase in the Apo and GM3 Ganglioside-bound Forms
J. Biol. Chem.,
May 11, 2007;
282(19):
14300 - 14308.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ishibashi, T. Nakasone, M. Kiyohara, Y. Horibata, K. Sakaguchi, A. Hijikata, S. Ichinose, A. Omori, Y. Yasui, A. Imamura, et al.
A Novel Endoglycoceramidase Hydrolyzes Oligogalactosylceramides to Produce Galactooligosaccharides and Ceramides
J. Biol. Chem.,
April 13, 2007;
282(15):
11386 - 11396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Horibata, K. Sakaguchi, N. Okino, H. Iida, M. Inagaki, T. Fujisawa, Y. Hama, and M. Ito
Unique Catabolic Pathway of Glycosphingolipids in a Hydrozoan, Hydra magnipapillata, Involving Endoglycoceramidase
J. Biol. Chem.,
August 6, 2004;
279(32):
33379 - 33389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Furusato, N. Sueyoshi, S. Mitsutake, K. Sakaguchi, K. Kita, N. Okino, S. Ichinose, A. Omori, and M. Ito
Molecular Cloning and Characterization of Sphingolipid Ceramide N-Deacylase from a Marine Bacterium, Shewanella alga G8
J. Biol. Chem.,
May 3, 2002;
277(19):
17300 - 17307.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|